Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovaza + Antara in Hypertriglyceridemia (2nd OLE)
NCT00891293Phase 4Completed
- Sponsor
- GSK
- Start
- Mar 2006
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of eicosapentaenoic acid + docosahexaenoic acid in hypertriglyceridemia, sponsored by GSK. Started Mar 2006; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT00891293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00891293.